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Background: Bacterial vaginosis is one of the most common genital tract infections among reproductive age
group. The prevalence of bacterial vaginosis varies from country to country even in the same country it varies
among populations of interest. Different social and sexual factors can contribute to the development of bacterial
vaginosis. The aim of this study was to determine the prevalence of bacterial vaginosis and to identify the possible
risk factors associated among pregnant women attending antenatal care in Tikur Anbessa University Hospital, Addis
Ababa, Ethiopia.
Methods: Randomly selected 57 symptomatic and 195 asymptomatic pregnant women aged between 18 and
40 years visiting obstetric and gynecological clinic from November 2011 to April 2012 screenedusing Gram stain
Nugent scoring system. Statistical analysis like univariate analysis to calculate frequencies and proportions, bivariate
analysis to see association of selected exposure variables with the outcome variable, and multivariate analysis to
check the association of possible factors with bacterial vaginosis by adjusting potential confounding factors was
calculated using SPSS (Version 16.0).
Results: The prevalence of bacterial vaginosis is 19.4% using Gram stain Nugent scoring system. In addition,
prevalence of bacterial vaginosis is 31.6% and 15.9% among symptomatic and asymptomatic pregnant women
respectively. A high percentage of bacterial vaginosis positive pregnant women were asymptomatic (63.3%). 36.7%
bacterial vaginosis positive pregnant women reported abnormal vaginal discharge with or without unpleasant
smell. Multiple lifetime sexual partner (OR: 8.6; 95% CI: 2.5, 29) and previous history of spontaneous abortion
(OR: 5.9; 95% CI: 1.5, 23) had remained significantly associated with prevalence of bacterial vaginosis.
Conclusion: The prevalence of bacterial vaginosis is higher among asymptomatic pregnant women and associated
with the factors previous history of multiple lifetime sexual partner and spontaneous abortion.
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Bacterial vaginosis (BV) is a shift in the vaginal ecosys-
tem characterized by an overgrowth of anaerobes, and a
decrease in Lactobacillus resulting in degradation of the
natural flora that helps keep the vaginal tissue healthy
[1]. It is a very common infection in women, and there
is a lack of understanding regarding the triggers and fac-
tors for the onset and resolution of it [2].* Correspondence: zemenumengistie@yahoo.com
1Department of Medical Microbiology, Mizan Tepi University, P.O. Box 260,
Mizan, Ethiopia
Full list of author information is available at the end of the article
© 2014 Mengistie et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Bacterial vaginosis is an important gynecologic problem
of childbearing age group of women worldwide. The pres-
ence of bacterial vaginosis has consistently been shown to
be a risk factor for adverse obstetric outcomes such as pre-
term labor and delivery, preterm premature rupture of
membranes, spontaneous abortion, and postpartum infec-
tions such as endometritis and caesarean section wound in-
fections [3-5]. It also increases the risk of HIV acquisition
by approximately 60 percent; because BV increases HIV
genital shedding with in discharge and results in increased
concentration of HIV in genital secretions, which in turn
facilitates both vertical and sexual HIV transmission [6-8].ral Ltd. This is an Open Access article distributed under the terms of the Creative
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pregnant women vary from 6.4 percent to 38 percent
[9,10]. It has been found that the lower the socioeco-
nomic status of the population, the higher the incidences
of bacterial vaginosis, which may indicate health and
hygiene factors, play an even bigger role than anticipated
[11]. The methods of diagnosis used for diagnosis ofBV
can also have an effect on the variation of BV preva-
lence. The gold standard for diagnosis of BV is micro-
scopic criteria proposed by Nugent [12]. The clinical
criteria by Amsel do not require laboratory facilities,
specialized staff and there is no delay in reporting. How-
ever, it is difficult to evaluate all of these criteria for
diagnosis of BV in busy practice; and it requires the abil-
ity of the gynecologist to analyze wet mount microscopy.
Although many studies of BV have been done in
different country,currently we know of no published
studies that have been conducted in Ethiopia to describe
the prevalence of BV among pregnant women. In order
to avoid the above aforementioned pregnancy complica-
tions during BV infection screening and treating of
pregnant women is crucial. Therefore, the present study
was carried out to determine the prevalence ofbacterial
vaginosis and associated factors among pregnant women
visiting antenatal care (ANC).Methods
Fifty seven symptomatic and 195 asymptomatic pregnant
women aging 18 to 40 years included in the study by
simple randomsampling technique. These were out-
patient clients visiting obstetrical and gynecological clin-
ical for antenatal care services of a tertiary level hospital
in Addis Ababa from November 2011 to April 2012. The
nurse interviewers performed a comprehensive review of
the prenatal and ultrasound record; and completed the
standardized baseline questionnaire containing informa-
tion regarding maternal age, gravidity, previous pregnancy
outcomes, demographic, vaginal hygiene and contracep-
tive use. Information on the presence and type of vaginal
discharge, history of sexual transmitted infection or genital
tract infection, history of BV, vaginal douching practices
and sexual practices also collected using questioner. The
questionnaires filled in a confidential location within the
office by a female nurse interviewer. Vaginal bleeding andTable 1 Prevalence of bacterial vaginosis based on Nugent sc
Tikur Anbessa university hospital (November 2011 - April 201
Microbiological diagnosis
Positive no. (%) Negative no. (%)
Symptomatic 18 (36.7) 39 (19.2)
Asymptomatic 31 (63.3) 164 (80.8)
Total 49 (19.4) 203 (80.6)antibiotic treatment in the preceding two weeks used as
exclusion criteria.
After physical and obstetrical examination by the at-
tending physician or obstetrician vaginal sample was col-
lected from lateral wall of the vagina and then smeared
on a slide and transported to microbiology department
for Gram staining for Nugent scoring. This is a stan-
dardized 0–10 point scoring system for evaluation of
Gram stained vaginal smears based on three morpho-
types: large gram positive rods (lactobacilli), small gram
negative/variable rods (G. vaginalisand anaerobic rods)
and curved gram variable rod (Mobiluncusspecies). A
score of 0–3 is considered normal, 4–6 intermediate, 7–10
positive for BV [12].
Data entered using EPI data then exported to SPSS
version 16.0 for analysis. Statistical analysis like univari-
ate analysis to calculate frequencies and proportions,
bivariate analysis to see association of selected exposure
variables with the outcome variable, and multivariate
analysis to cheek the association of possible factors with
bacterial vaginosis for adjusting potential confounding
factors calculated using SPSS.
The Research and Ethical Review Committee (REC) of
Addis Ababa University approved the research project
proposal. Written informed consent obtained from will-
ing pregnant women and symptomatic pregnant women
having BV positive treated by 500 mg oral metronidazole
twice daily for seven days.
Results
The mean age of the study participant was 27.6 (±4.7)
years and all are resident in urban. In addition nearly all
241(95.6%) of the study participants were married and
201(79.8%) had only one lifetime sexual partner. Among
161(63.9%) multigravida pregnant women, 24 (14.9%) of
pregnant women had previous history of spontaneous
abortion. None of the study participants had vaginal
douching practice in the preceding month.
The Gram stain result of 183(72.6%) study participant
classified as normal, 20 (7.9%) participant diagnosed as
an intermitted while the remaining 49 (19.4%) were posi-
tive for bacterial vaginosis by Nugent scoring system. As
shown in Table 1, the prevalence of bacterial vaginosis
among symptomatic pregnant was 18(31.6%) but among
asymptomatic the prevalence of BV was 31(15.9%).oring system among pregnant women attending ANC in
2)
Odd ratio p- value
Total no. (%)
57 (22.6) 2.44 < 0.05 (0.032)
195 (77.4) 1.00
252 (100)
Table 2 Univariate & Multivariate analysis of factors association with bacterial vaginosis among pregnant women
attending ANC in Tikur Anbessa Hospital (November 2011 - April 2012)
Variables BV positive BV negative Univariate; COR (95% CI) Multivariate; AOR (95% CI) p-value
Age (year)
≤20 3(17.6) 14(82.4) 1.09(0.27, 4.33)
21-29 33(21.2) 123(78.8) 1.36(0.67, 2.77)
30+ 13(16.5) 66(83.5) 1.00
Religion
Orthodox 40(22.2) 140(77.8) 1.00
Muslim 7(13.7) 44(86.3) 0.56(0.23, 1.33)
Protestant 2(9.5) 19(90.5) 0.37(0,08, 1.65)
Education
< Grade 12 complete 25(23.1) 83(76.9) 1.51(0.81, 2.82)
≥ Grade 12 complete 24(16.7) 120(83.3) 1.00
Occupation
Employed 19(18.1) 86(81.9) 1.00
House wife 24(20.3) 94(79.7) 1.16(0.59, 2.26)
Others 6(20.7) 23(79.3) 1.18(0.42, 3.3)
Income (ETB)
≤500 29(31.5) 63(68.5) *5.26(2.16, 12.8) 3(0.6, 14.6) 0.17
501-1500 13(17.8) 60(82.2) 2.48(0.93, 6.58)
>1500 7(8.0) 80(92.0) 1.00
Number of LTSP
One 20(10) 181(90) 1.00
Two and above 29(56.9) 22(43.1) *11.9(5.8, 24.5) 8.6(2.5, 29) 0.01*
Gestational age
1st trimester 13(36.1) 23(63.9) *3.46(1.48, 8.1) 1.9(0.4, 8.6) 0.40
2nd trimester 19(20) 76(80) 1.53(0.75, 3.14)
3rd trimester 17(14) 104(86) 1.00
Number of pregnancy
Primigravidia 17(18.7) 74(81.3) 1.00
Multigravidia 32(19.9) 129(80.1) 1.08(0.56, 2.08)
History of abortion
Yes-spontaneous 12(50) 12(50) *6.28(2.45, 16.11) 5.9(1.3, 23) 0.012*
Yes-induce 2(33.3) 4(66.7) 3.14(0.54, 18.41)
No 18(14) 113(86.3) 1.00
Vaginal bathing
Daily 46(18.8) 199(81.2) 0.31(0.07, 1.43)
Less than daily 3(42.9) 4(57.1) 1.00
Showering frequency
Daily 16(57.1) 12(42.9) *7.72(3.35, 17.78) 2.7(0.6, 12) 0.19
Less than daily 33(14.7) 191(85.3) 1.00
Previous BV/GTI
Yes 3(15) 17(85) 1.4(0.39, 4.99)
No 46(19.8) 186(80.2) 1.00
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Table 2 Univariate & Multivariate analysis of factors association with bacterial vaginosis among pregnant women
attending ANC in Tikur Anbessa Hospital (November 2011 - April 2012) (Continued)
Yeast infection
Yes 9(32.1) 19(67.9) 2.18(0.92, 5.17)
No 40(17.9) 184(82.1) 1.00
COR – Crude Odd Ratio; AOR – Adjusted Odd Ratio LTSP – Life Time Sexual Partner; ETB- Ethiopian Birr GTI- Genital Tract Infection; *statistically significant.
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nant women were asymptomatic.
More vaginal symptoms were reported from BV nega-
tive pregnant women than BV positive pregnant women
but abnormal discharge with unpleasant smell was re-
ported more frequently by BV positive women. Out of
unusual vaginal discharge complained women only 27
(47.4%) had non-Candida like discharge and non-Candida
like discharge is significantly associated with BV.
In the Bivariate analysis (Table 2) personal monthly
income ≤500 ETB, multiple sexual partners history, first
trimester gestational age and previous history of spon-
taneous abortion, daily showering were associated with
bacterial vaginosis(P < 0.05). However, after we had ad-
justed for confounders in multivariate analyses (Table 2),
more than one lifetime sexual partners and previous
history of spontaneous abortion remained independently
associated with increased likelihood of BV positive.
Some factors that lacked independent associations with
BV during pregnancy remained important confounders
and were therefore retained in the final model.
Discussion
The overall prevalence of bacterial vaginosis by Gram
stains Nugent scoring criteria in this study was 19.4%,
which was comparable with studies done in India (20.5%)
and in Denmark (17%) [13,14]. The current study
showed lower prevalence of bacterial vaginosis than re-
ports from different sub-Saharan countries like Kenya
(37%), Botswana (38%), Zimbabwe (32.5%) using the
same methods of diagnosis [10,15,16]. The lower preva-
lence of BV in our study may be due to that absence of
vaginal douching among study population. Besides these,
the lower prevalence of BV in this study can be also ex-
plained as most of the women were in third trimester
gestational age since as gestational age increase the preva-
lence of BV decrease. In contrast to the present study,
lower prevalence of bacterial vaginosis was reported in
Burkina Faso (6.4%), India (8.6%), Sweden (9.3%), Boston
(11%) and Washington (12%) [9,17-20]. This may be due
to environmental, behavioral, socioeconomic status and
stressor differences in the geographical variation.
Bacterial vaginosis is mostly present without sign and
symptoms. The most common clinical sign and symp-
toms of BV is thin white or gray homogenous vaginal
discharge with or without unpleasant smell. The smell ofthe discharge mostly noticed after sexual intercourse
[3,21,22]. In the current study, we found that 63.3% of
participants who were diagnosed positive for BV by
gram stain had no symptom for BV. This result is con-
sistent with other studies done in different countries
[10,23,24]. In this study the result also showed that the
Vaginal discharge complains by women has less value as
diagnostic algorithm because approximately one-third
(31.6%) of BV positive participants were only reported
abnormal discharge when asked. The finding are consist-
ent with other study which report that only very few
women reported vaginal symptom when asked [15].
Comparing with a women having Candida like discharge,
pregnant women with non-Candida like abnormal dis-
charge had a greater chance (OR: 4.6; 95% CI: 1.4, 15.7;
p = 0.014) to be positive for bacterial vaginosis.
In addition, our result also found that the presence of
abnormal vaginal discharge (p = 0.01) and unpleasant
smell (p = 0.005) were reported vaginal symptoms associ-
ated with bacterial vaginosis. In general abnormal vagi-
nal discharge is not accurate sensitive indicator of BV
status in this study which confirms the suggestions by
other studies [10,25]; but symptomatic pregnant women
have more than a twofold increased chance to be posi-
tive for bacterial vaginosis than asymptomatic.
With consideration to the above findings, it can be
concluded that bacterial vaginosis has a varying degree
of prevalence rate among people of different communi-
ties which might be due to certain factors such as hy-
giene behaviors and sociodemographic characteristics.
Therefore, it is important to try to establish a correlation
between BV and factors affecting its prevalence. Because
our sample population was exclusively urban living and
nearly all women were married, had no previous history
of preterm and stillbirth and had daily vaginal bathing,
we could not effectively examine the association of BV
with these risk factors. As well, we were unable to com-
pare the frequency of bacterial vaginosis among religious
denominations due to lack of comparability in the num-
ber of participants. In our study, there was a significant
correlation between number of lifetime sexual partner
and prevalence of BV. Multiple lifetime sexual partners
were more likely risk factors for bacterial vaginosis. This
is consistent with other researcher findings [3,26-28];
while others finding showed no significant correlation in
this regard [29]. In addition to this factor, consistent
Mengistie et al. BMC Research Notes 2014, 7:822 Page 5 of 5
http://www.biomedcentral.com/1756-0500/7/822with other study done among pregnant women in Burkina
Faso [9]; we found that previous spontaneous abortion is
independently associated as a risk factor of bacterial vagin-
osis infection.
Conclusion
The overall prevalence of bacterial vaginosis among pregnant
women is 19.4%. The prevalence of BV among symptomatic
pregnant women was 31.6% while among asymptomatic
pregnant women, it was 15.9% and BV infection is mostly
asymptomatic. Since common asymptomatic nature of BV
infection, screening of women having an experience of mul-
tiple lifetime sexual partner and previous history of spon-
taneous abortion is vital for good pregnancy outcome.
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